Scalper1 News
Medical products maker Covidien (COV) beat fiscal Q1 expectations Friday morning, sending its stock up 5% to a new high on the stock market today. Covidien’s revenue rose 3% over the year-earlier quarter to $2.64 billion, beating analysts’ consensus by about $40 million. Profit excluding special items also rose 3% to $1 a share, 6 cents above estimates. The company raised its tax-rate guidance for fiscal 2014 (which ends in September) to Scalper1 News
Scalper1 News